Douglas Doerfler Maxcyte, Inc. (MXCT) insider trading activity

Douglas Doerfler is President and CEO of MAXCYTE, INC.. Currently has a direct ownership of 333,197 shares of MXCT, which is worth approximately $1.19 Million. The most recent transaction as insider was on Dec 05, 2023, when has been sold 99,442 shares (Common Stock) at a price of $5.17 per share, resulting in proceeds of $514,115. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 333K

0% 3M change

0% 12M change

Total Value Held $1.19 Million

Douglas Doerfler Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 05 2023	SELL Open market or private sale	$514,115 $5.17 p/Share	99,442 Reduced 22.98%	333,197 Common Stock
Dec 05 2023	BUY Exercise of conversion of derivative security	$3,977 $0.04 p/Share	99,442 Added 18.69%	432,639 Common Stock
Dec 04 2023	SELL Open market or private sale	$125,290 $5.01 p/Share	25,008 Reduced 6.98%	333,197 Common Stock
Dec 04 2023	BUY Exercise of conversion of derivative security	$1,000 $0.04 p/Share	25,008 Added 6.53%	358,205 Common Stock
Dec 01 2023	SELL Open market or private sale	$101,000 $5.0 p/Share	20,200 Reduced 5.72%	333,197 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$808 $0.04 p/Share	20,200 Added 5.41%	353,397 Common Stock
Nov 29 2023	SELL Open market or private sale	$26,750 $5.0 p/Share	5,350 Reduced 1.58%	333,197 Common Stock
Nov 29 2023	BUY Exercise of conversion of derivative security	$214 $0.04 p/Share	5,350 Added 1.56%	338,547 Common Stock
Jul 12 2023	SELL Open market or private sale	$84,120 $5.02 p/Share	16,757 Reduced 4.79%	333,197 Common Stock
Jul 12 2023	BUY Exercise of conversion of derivative security	$670 $0.04 p/Share	16,757 Added 4.57%	349,954 Common Stock
Jul 11 2023	SELL Open market or private sale	$64,501 $5.04 p/Share	12,798 Reduced 3.7%	333,197 Common Stock
Jul 11 2023	BUY Exercise of conversion of derivative security	$511 $0.04 p/Share	12,798 Added 3.57%	345,995 Common Stock
Jul 10 2023	SELL Open market or private sale	$2,229 $5.01 p/Share	445 Reduced 0.13%	333,197 Common Stock
Jul 10 2023	BUY Exercise of conversion of derivative security	$17 $0.04 p/Share	445 Added 0.13%	333,642 Common Stock
Jun 14 2023	SELL Open market or private sale	$145,570 $5.04 p/Share	28,883 Reduced 7.98%	333,197 Common Stock
Jun 14 2023	BUY Exercise of conversion of derivative security	$1,155 $0.04 p/Share	28,883 Added 7.39%	362,080 Common Stock
Jun 13 2023	SELL Open market or private sale	$75,289 $5.03 p/Share	14,968 Reduced 4.3%	333,197 Common Stock
Jun 13 2023	BUY Exercise of conversion of derivative security	$598 $0.04 p/Share	14,968 Added 4.12%	348,165 Common Stock
May 03 2023	SELL Open market or private sale	$81,067 $5.02 p/Share	16,149 Reduced 4.62%	333,197 Common Stock
May 03 2023	BUY Exercise of conversion of derivative security	$645 $0.04 p/Share	16,149 Added 4.42%	349,346 Common Stock
Apr 12 2023	SELL Open market or private sale	$63,590 $5.0 p/Share	12,718 Reduced 3.68%	333,197 Common Stock
Apr 12 2023	BUY Exercise of conversion of derivative security	$508 $0.04 p/Share	12,718 Added 3.55%	345,915 Common Stock
Apr 11 2023	SELL Open market or private sale	$10,910 $5.0 p/Share	2,182 Reduced 0.65%	333,197 Common Stock
Apr 11 2023	BUY Exercise of conversion of derivative security	$87 $0.04 p/Share	2,182 Added 0.65%	335,379 Common Stock
Apr 10 2023	SELL Open market or private sale	$500 $5.0 p/Share	100 Reduced 0.03%	333,197 Common Stock

Douglas Doerfler

President and CEO

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MXCT shares.

Notify only if

Value

Insider Trading

Get notified when an Maxcyte, Inc. insider buys or sells MXCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to MAXCYTE, INC.

Track Activities on MXCT

Account